A Randomized, Double-blind, 2-Period, Placebo-Controlled Crossover Trial of a Sustained-Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.